Pharmafile Logo
Pharmafocus logo
Advanced Search

transparency

Showing 15 posts of 93 posts found.

Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013
Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …

News
Europe image

Europe votes yes on greater trial transparency

June 3, 2013
Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …

News
NICE image

Grant NICE greater trial data access – report

May 29, 2013
Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials

A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …

News
EMA image

Court rules against EMA disclosure

May 2, 2013
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency

The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …

News
abpi_reception

‘No consensus’ on transparency

April 22, 2013
Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …

News
Humira image

AbbVie guards Humira data

March 13, 2013
Sales and Marketing AbbVie, Abbott, Humira, RA, transparency

AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …

News
LaMattina image

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …

Feature
Records image

NHS patient data and clinical research – coming together at last?

January 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, NHS, R&D, clinical, records, transparency

In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …

Feature
EMA image

EMA’s five points on data release

November 27, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …

News

EFPIA rejects ‘indiscriminate’ transparency

November 16, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials

Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …

News

EMA backs full access to trial data

April 12, 2012
Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency

The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …

News

FDA goes public with enforcement actions

June 2, 2011
Manufacturing and Production FDA, transparency

The FDA is to publish more details about inspections and court actions on its website as part of a drive …

News
Food and Drug Administration (FDA)

FDA launches online transparency initiative

January 11, 2011
Medical Communications, Research and Development, Sales and Marketing FDA, Joshua Sharfstein, transparency

The FDA has launched a new online resource to increase the transparency of its processes and help save companies time …

News

EMA to widen public access to documents

December 1, 2010
Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency

The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …

News

European pharma expects regulatory compliance challenges

November 18, 2010
Sales and Marketing CRM, Cegedim Dendrite, Transparency Directive, regulatory compliance, transparency

European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023